Medication info
DuoMet XR Tablet 500/5 mg

DuoMet XR Tablet 500/5 mg

Prescription medicationTabletOralApproval revoked
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Approval revoked

MFDS item code 201903373 · Approved 2019.05.24 · Insurance code 645405510

This product's status changed to Approval revoked on 2026.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Combination replacement therapy with metformin and rosuvastatin
Who takes it
Adults
Adult dose
This drug is for adults only and is administered once daily with the evening meal. For patients taking metformin hydrochloride and rosuvastatin calcium concomitantly, switch to this drug (a combination product with the same content of each active ingredient) for convenience of administration. The safety and efficacy of this drug were established at a metformin hydrochloride dose of 1500 mg.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Combination replacement therapy with metformin and rosuvastatin

View approved original text

This drug is used as a combined replacement therapy for patients who need to take both Metformin Hydrochloride and Rosuvastatin Calcium simultaneously.

How to take

Adult dose

This drug is for adults only and is administered once daily with the evening meal. For patients taking metformin hydrochloride and rosuvastatin calcium concomitantly, switch to this drug (a combination product with the same content of each active ingredient) for convenience of administration. The safety and efficacy of this drug were established at a metformin hydrochloride dose of 1500 mg.

Precautions

This drug can rarely cause a metabolic complication known as lactic acidosis, which can lead to death. Lactic acidosis is particularly dangerous in patients with impaired kidney function or conditions such as cardiopulmonary disease and sepsis, so caution is necessary. Additionally, when taken with insulin or sulfonylurea drugs, hypoglycemic symptoms may be significantly pronounced, so blood sugar should be closely monitored. This drug should not be administered to patients with certain liver diseases, muscle disorders, renal impairment, pregnant or breastfeeding women, and those with specific genetic metabolic disorders. In particular, patients with severely impaired kidney function or acute conditions such as acute heart failure, severe infections, or myocardial infarction should not use this drug. Moreover, the intake of this drug should be temporarily stopped before and after undergoing tests with iodine contrast agents, and it should be restarted only after kidney function has been confirmed to be normal. During the course of taking this drug, regular kidney and liver function tests should be conducted, and if any unusual symptoms such as muscle pain or fatigue appear, the healthcare provider should be notified immediately. Mild side effects such as gastrointestinal disturbances, headaches, dizziness, and skin rashes may occur, and in rare cases, severe skin reactions or muscle disorders may occur, so caution is required. Alcohol consumption can increase the risk of lactic acidosis, so it is advisable to avoid it while taking this drug. For elderly patients or those with reduced kidney function, dosage adjustments and regular monitoring are important, and pregnant women or those who may become pregnant should not take this medication. This drug may interact with other medications, so if other drugs are being taken, it is essential to inform the healthcare provider, especially when taken with medications affecting the liver or kidneys. In case of overdose, immediate medical treatment is required, and the components of this drug can be removed via dialysis, but there is no specific antidote. Lastly, this drug should be stored out of reach of children, kept in its original container, and caution should be exercised as dizziness may occur when driving or operating machinery.

Side effects

severe lactic acidosis, severe hypoglycemia, diarrhea, upper abdominal pain, constipation, abdominal pain, belching, gastroesophageal reflux disease, upper abdominal discomfort, dyspepsia, cellulitis, paresthesia, arthralgia, papular rash, increased creatine phosphokinase, elevated liver enzymes, hypothermia, diarrhea, dyspepsia, upper abdominal discomfort, chronic gastritis, herpes zoster, decreased vitamin B12 absorption and plasma levels, taste impairment, nausea, vomiting, diarrhea, abdominal pain, anorexia, erythema, pruritus, urticaria, angioedema, hypersensitivity reaction, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, increased ALT, chest pain, cough, myalgia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, paresthesia, chest discomfort, nausea, abdominal pain, diarrhea, anorexia, abdominal distention, pruritus, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent air or moisture from entering, and it should be kept at a safe temperature between 1 and 30 degrees Celsius. By doing so, the efficacy of the drug can be maintained for a longer period.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.